Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

NCT02581995 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema

Interventions

DRUG: Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer